This protocol is judged by an institutional evaluation board, an unbiased team that assessments any clinical trials involving individuals. If a examine will involve a Agenda I drug, after the board approves the protocol as moral, the researchers need to make an application for an investigational new drug (IND) selection within the FDA.If this is t